HIV Stocks List

Related ETFs - A few ETFs which own one or more of the above listed HIV stocks.

HIV Stocks Recent News

Date Stock Title
May 20 NNVC Lethally RSV Infected Animals Orally Treated with NV-387 Showed Normal Lung Histology, Indicating Potential Cure
May 19 GILD Biopharma M&A surges year over year in Q1
May 18 GSK Novo Nordisk, J&J lead R&D rankings in big pharma: report
May 18 GILD Investigational Seladelpar Demonstrates Significant Improvements in Liver Disease Progression and Reduced Itching in Primary Biliary Cholangitis
May 17 GOVX GeoVax to Raise Approximately $1.3 Million of Gross Proceeds in Offering Priced At-the-Market
May 17 GSK GSK sale of remaining Haleon stake nets more than $1.5B
May 17 GSK GlaxoSmithKline Pharma India posts higher Q4 adjusted profit on strong sales
May 17 GSK FTSE 100 Live 17 May: LandSec shares fall on results, GSK in £1.25bn final Haleon stake sale
May 17 GSK Trending tickers: Tesla, Reddit, Walmart and GSK
May 17 GSK GSK to Sell Remaining $1.6 Billion Stake in Haleon
May 16 GSK GSK to sell entire Haleon stake
May 16 AIM AIM ImmunoTech Inc. (AIM) Q1 2024 Earnings Call Transcript
May 16 LH Insider Sale: EVP, Chief Legal Officer van der Vaart Sandra D Sells Shares of Laboratory Corp ...
May 16 LH Labcorp (LH) to Assess Preeclampsia Risk With New Test
May 16 AIM AIM ImmunoTech GAAP EPS of -$0.12
May 16 AIM AIM ImmunoTech Reports First Quarter 2024 Financial Results and Provides Corporate Update
May 16 LH Labcorp launches first trimester preeclampsia screening test
May 15 GILD Gilead Sciences, Inc. (GILD) RBC Capital Markets Global Healthcare Conference (Transcript)
May 15 AIM AIM ImmunoTech Q1 2024 Earnings Preview
May 15 LH Labcorp Introduces First Trimester Screening Test to Assess Preeclampsia Risk during Pregnancy
HIV

The human immunodeficiency virus (HIV) is a lentivirus (a subgroup of retrovirus) that causes HIV infection and over time acquired immunodeficiency syndrome (AIDS). AIDS is a condition in humans in which progressive failure of the immune system allows life-threatening opportunistic infections and cancers to thrive. Without treatment, average survival time after infection with HIV is estimated to be 9 to 11 years, depending on the HIV subtype. In most cases, HIV is a sexually transmitted infection and occurs by contact with or transfer of blood, pre-ejaculate, semen, and vaginal fluids. Non-sexual transmission can occur from an infected mother to her infant during pregnancy, during childbirth by exposure to her blood or vaginal fluid, and through breast milk. Within these bodily fluids, HIV is present as both free virus particles and virus within infected immune cells.
HIV infects vital cells in the human immune system, such as helper T cells (specifically CD4+ T cells), macrophages, and dendritic cells. HIV infection leads to low levels of CD4+ T cells through a number of mechanisms, including pyroptosis of abortively infected T cells, apoptosis of uninfected bystander cells, direct viral killing of infected cells, and killing of infected CD4+ T cells by CD8+ cytotoxic lymphocytes that recognize infected cells. When CD4+ T cell numbers decline below a critical level, cell-mediated immunity is lost, and the body becomes progressively more susceptible to opportunistic infections, leading to the development of AIDS.

Browse All Tags